Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review | Breast Cancer Research | Full Text

Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review | Breast Cancer Research | Full Text

Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review

Metastatic triple-negative breast cancer (mTNBC), an aggressive histological subtype, has poor prognosis. Chemotherapy remains standard of care for mTNBC, although no agent has been specifically approved for t...

Authors:Claire H. Li, Vassiliki Karantza, Gursel Aktan and Mallika Lala

Citation:Breast Cancer Research 2019 21:143

Content type:Research article

Published on: 16 December 2019

• ViewFull Text
 
• ViewPDF